Target Price | €173.40 |
Price | €102.50 |
Potential |
69.17%
register free of charge
|
Number of Estimates | 13 |
13 Analysts have issued a price target Redcare Pharmacy 2026 .
The average Redcare Pharmacy target price is €173.40.
This is
69.17%
register free of charge
€224.70
119.22%
register free of charge
€82.82
19.20%
register free of charge
|
|
A rating was issued by 16 analysts: 12 Analysts recommend Redcare Pharmacy to buy, 2 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Redcare Pharmacy stock has an average upside potential 2026 of
69.17%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion € | 2.37 | 3.02 |
31.79% | 27.31% | |
EBITDA Margin | 1.26% | 2.16% |
54.51% | 71.94% | |
Net Margin | -1.92% | -0.73% |
186.50% | 61.93% |
12 Analysts have issued a sales forecast Redcare Pharmacy 2025 . The average Redcare Pharmacy sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Redcare Pharmacy EBITDA forecast 2025. The average Redcare Pharmacy EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
14 Redcare Pharmacy Analysts have issued a net profit forecast 2025. The average Redcare Pharmacy net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | -2.27 | -1.10 |
260.32% | 51.54% | |
P/E | negative | |
EV/Sales | 0.72 |
14 Analysts have issued a Redcare Pharmacy forecast for earnings per share. The average Redcare Pharmacy EPS is
This results in the following potential growth metrics and future valuations:
Redcare Pharmacy...
Analyst | Rating | Action | Date |
---|---|---|---|
METZLER EQUITIES |
Locked
➜
Locked
|
Locked | Jul 17 2025 |
JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jul 02 2025 |
BERENBERG |
Locked
➜
Locked
|
Locked | Jun 30 2025 |
HSBC |
Locked
➜
Locked
|
Locked | May 25 2025 |
HAUCK AUFHAEUSER INVESTMENT BANKING |
Locked
➜
Locked
|
Locked | May 06 2025 |
MWB RESEARCH AG |
Locked
➜
Locked
|
Locked | May 06 2025 |
Analyst Rating | Date |
---|---|
Locked
METZLER EQUITIES:
Locked
➜
Locked
|
Jul 17 2025 |
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 16 2025 |
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Jul 02 2025 |
Locked
BERENBERG:
Locked
➜
Locked
|
Jun 30 2025 |
Locked
HSBC:
Locked
➜
Locked
|
May 25 2025 |
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
➜
Locked
|
May 06 2025 |
Locked
MWB RESEARCH AG:
Locked
➜
Locked
|
May 06 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.